
Pharmaceutical Representative
According to a study in the Journal of the American Medical Association (vol. 283, no. 8) prescriptions of mood-altering drugs in two to four year olds increased from the years 1991 to 1995. The study examined three psychotropic medication classes: stimulants, antidepressants and neuroleptics, and looked at pharmacy data in patients from two Medicaid programs and one HMO finding that "Sizeable increases in prevalence were noted between 1991 and 1995 across the three sites for clonidine, stimulants and antidepressants while neuroleptic use increased only slightly." The study concluded, however, that, because of the number of medications with off-label indications, community-based, multidimensional outcome studies would be called for.